| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Antigen, T-Cell, gamma-delta | 22 | 2023 | 102 | 5.740 |
Why?
|
| T-Lymphocytes | 29 | 2023 | 1195 | 4.360 |
Why?
|
| Histocompatibility Antigens Class I | 22 | 2024 | 203 | 3.230 |
Why?
|
| Antigen Presentation | 17 | 2024 | 209 | 3.060 |
Why?
|
| Lymphocyte Activation | 22 | 2024 | 728 | 3.050 |
Why?
|
| Antigens, CD1 | 7 | 2016 | 35 | 2.270 |
Why?
|
| T-Lymphocyte Subsets | 8 | 2020 | 272 | 1.980 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 10 | 2024 | 100 | 1.670 |
Why?
|
| Butyrophilins | 10 | 2020 | 22 | 1.630 |
Why?
|
| Antigens, CD | 10 | 2018 | 458 | 1.610 |
Why?
|
| Antigens, CD1d | 8 | 2015 | 29 | 1.500 |
Why?
|
| Receptors, Antigen, T-Cell | 14 | 2024 | 372 | 1.460 |
Why?
|
| Glycoproteins | 6 | 2016 | 234 | 1.300 |
Why?
|
| Lipids | 4 | 2018 | 269 | 1.300 |
Why?
|
| Antibodies, Monoclonal | 5 | 2023 | 1376 | 1.260 |
Why?
|
| Minor Histocompatibility Antigens | 8 | 2024 | 39 | 1.260 |
Why?
|
| Complementarity Determining Regions | 3 | 2020 | 24 | 1.210 |
Why?
|
| Mucosal-Associated Invariant T Cells | 6 | 2024 | 11 | 1.150 |
Why?
|
| Models, Molecular | 10 | 2018 | 1286 | 1.100 |
Why?
|
| Genes, MHC Class I | 10 | 2014 | 48 | 1.050 |
Why?
|
| Killer Cells, Natural | 7 | 2017 | 267 | 1.000 |
Why?
|
| Ligands | 15 | 2024 | 433 | 1.000 |
Why?
|
| Phosphatidylserines | 5 | 2023 | 20 | 0.990 |
Why?
|
| Protein Binding | 23 | 2020 | 1456 | 0.980 |
Why?
|
| Evolution, Molecular | 8 | 2015 | 813 | 0.930 |
Why?
|
| Antigens | 14 | 2024 | 228 | 0.900 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2023 | 81 | 0.890 |
Why?
|
| Pan troglodytes | 10 | 2015 | 197 | 0.880 |
Why?
|
| Animals | 54 | 2021 | 26582 | 0.880 |
Why?
|
| Protein Conformation | 13 | 2017 | 881 | 0.850 |
Why?
|
| Major Histocompatibility Complex | 4 | 2019 | 81 | 0.820 |
Why?
|
| Superantigens | 1 | 2021 | 24 | 0.820 |
Why?
|
| Clostridiales | 1 | 2021 | 17 | 0.820 |
Why?
|
| Recombinant Proteins | 6 | 2020 | 1014 | 0.820 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2021 | 131 | 0.800 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2021 | 109 | 0.800 |
Why?
|
| Protein Multimerization | 3 | 2020 | 173 | 0.790 |
Why?
|
| Antigens, Bacterial | 4 | 2014 | 134 | 0.790 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2021 | 113 | 0.770 |
Why?
|
| Antibody Affinity | 1 | 2020 | 38 | 0.770 |
Why?
|
| Antibody Specificity | 1 | 2020 | 129 | 0.760 |
Why?
|
| Inclusion Bodies | 1 | 2020 | 34 | 0.730 |
Why?
|
| Sulfoglycosphingolipids | 3 | 2013 | 7 | 0.680 |
Why?
|
| B-Lymphocytes | 5 | 2021 | 724 | 0.620 |
Why?
|
| Host-Pathogen Interactions | 1 | 2020 | 231 | 0.610 |
Why?
|
| Crystallography, X-Ray | 12 | 2018 | 485 | 0.600 |
Why?
|
| Protein Structure, Tertiary | 8 | 2015 | 736 | 0.600 |
Why?
|
| Mice | 21 | 2021 | 11352 | 0.590 |
Why?
|
| Primates | 3 | 2011 | 151 | 0.580 |
Why?
|
| Autoantigens | 3 | 2017 | 127 | 0.570 |
Why?
|
| Software | 1 | 2020 | 654 | 0.570 |
Why?
|
| Humans | 70 | 2024 | 86643 | 0.550 |
Why?
|
| Peptides | 6 | 2021 | 639 | 0.520 |
Why?
|
| Mycobacterium | 1 | 2014 | 17 | 0.510 |
Why?
|
| HLA Antigens | 5 | 2019 | 232 | 0.510 |
Why?
|
| Mycobacterium tuberculosis | 5 | 2016 | 186 | 0.490 |
Why?
|
| Lipid Mobilization | 1 | 2013 | 2 | 0.480 |
Why?
|
| Cell Line | 16 | 2023 | 2468 | 0.480 |
Why?
|
| Organophosphorus Compounds | 3 | 2020 | 55 | 0.480 |
Why?
|
| Binding Sites | 10 | 2021 | 1098 | 0.470 |
Why?
|
| Immunity, Cellular | 1 | 2014 | 177 | 0.460 |
Why?
|
| Natural Killer T-Cells | 6 | 2013 | 39 | 0.460 |
Why?
|
| Membrane Proteins | 3 | 2021 | 1196 | 0.450 |
Why?
|
| Amino Acid Sequence | 16 | 2021 | 2062 | 0.450 |
Why?
|
| Polymorphism, Genetic | 7 | 2014 | 819 | 0.430 |
Why?
|
| Molecular Sequence Data | 18 | 2014 | 3030 | 0.430 |
Why?
|
| Receptors, Immunologic | 4 | 2017 | 135 | 0.420 |
Why?
|
| Genes, Immunoglobulin Heavy Chain | 1 | 2011 | 9 | 0.410 |
Why?
|
| Lectins, C-Type | 3 | 2017 | 85 | 0.390 |
Why?
|
| HLA-C Antigens | 6 | 2010 | 21 | 0.380 |
Why?
|
| Epitopes | 4 | 2023 | 255 | 0.380 |
Why?
|
| Hepatitis A Virus Cellular Receptor 1 | 4 | 2021 | 19 | 0.370 |
Why?
|
| Antibodies | 1 | 2012 | 350 | 0.370 |
Why?
|
| Antigens, Ly | 2 | 2007 | 37 | 0.360 |
Why?
|
| Protein Structure, Secondary | 5 | 2021 | 330 | 0.350 |
Why?
|
| Immunity, Innate | 1 | 2013 | 409 | 0.350 |
Why?
|
| Hemiterpenes | 2 | 2020 | 6 | 0.340 |
Why?
|
| Structure-Activity Relationship | 4 | 2017 | 408 | 0.320 |
Why?
|
| Genetic Variation | 6 | 2011 | 1351 | 0.310 |
Why?
|
| Muromegalovirus | 1 | 2007 | 1 | 0.310 |
Why?
|
| Conserved Sequence | 4 | 2012 | 210 | 0.300 |
Why?
|
| CD3 Complex | 2 | 2019 | 135 | 0.300 |
Why?
|
| Diphosphates | 2 | 2018 | 18 | 0.300 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2021 | 295 | 0.290 |
Why?
|
| Base Sequence | 11 | 2014 | 2330 | 0.290 |
Why?
|
| Histocompatibility Antigens | 3 | 2019 | 35 | 0.270 |
Why?
|
| CRISPR-Cas Systems | 2 | 2023 | 70 | 0.270 |
Why?
|
| Epitopes, T-Lymphocyte | 3 | 2017 | 89 | 0.260 |
Why?
|
| Cross Reactions | 2 | 2020 | 106 | 0.260 |
Why?
|
| Protein Isoforms | 4 | 2014 | 270 | 0.260 |
Why?
|
| Computational Biology | 3 | 2020 | 528 | 0.250 |
Why?
|
| Ribitol | 1 | 2024 | 1 | 0.250 |
Why?
|
| Uracil | 1 | 2024 | 72 | 0.240 |
Why?
|
| Pongo pygmaeus | 2 | 2002 | 10 | 0.240 |
Why?
|
| Galactosylceramides | 2 | 2013 | 8 | 0.230 |
Why?
|
| Gene Editing | 1 | 2023 | 42 | 0.230 |
Why?
|
| Protein Structure, Quaternary | 3 | 2013 | 99 | 0.220 |
Why?
|
| Proteins | 2 | 2005 | 777 | 0.220 |
Why?
|
| Mice, Inbred C57BL | 5 | 2021 | 3092 | 0.220 |
Why?
|
| Cell Membrane | 3 | 2023 | 666 | 0.220 |
Why?
|
| Phylogeny | 8 | 2014 | 1137 | 0.210 |
Why?
|
| Phosphorylation | 4 | 2018 | 1106 | 0.210 |
Why?
|
| Models, Immunological | 2 | 2014 | 80 | 0.210 |
Why?
|
| Thymus Gland | 3 | 2021 | 195 | 0.210 |
Why?
|
| Species Specificity | 6 | 2016 | 678 | 0.210 |
Why?
|
| Escherichia coli | 3 | 2018 | 597 | 0.210 |
Why?
|
| Alleles | 9 | 2002 | 1128 | 0.210 |
Why?
|
| Mucins | 1 | 2021 | 39 | 0.200 |
Why?
|
| Clone Cells | 4 | 2017 | 213 | 0.200 |
Why?
|
| Cattle | 3 | 2017 | 376 | 0.190 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2021 | 77 | 0.190 |
Why?
|
| Histocompatibility Antigens Class II | 4 | 2021 | 158 | 0.190 |
Why?
|
| Protein Refolding | 1 | 2020 | 2 | 0.190 |
Why?
|
| Carrier Proteins | 1 | 2023 | 673 | 0.180 |
Why?
|
| Riboflavin | 1 | 2019 | 6 | 0.180 |
Why?
|
| Sequence Homology, Nucleic Acid | 5 | 2014 | 173 | 0.180 |
Why?
|
| CD4 Antigens | 1 | 2019 | 83 | 0.180 |
Why?
|
| Gorilla gorilla | 2 | 2014 | 41 | 0.170 |
Why?
|
| Immunologic Surveillance | 1 | 2019 | 14 | 0.170 |
Why?
|
| MART-1 Antigen | 1 | 2018 | 19 | 0.170 |
Why?
|
| Receptors, Natural Killer Cell | 2 | 2017 | 20 | 0.170 |
Why?
|
| Mycobacterium smegmatis | 1 | 2018 | 6 | 0.170 |
Why?
|
| Hepatitis A Virus Cellular Receptor 2 | 2 | 2018 | 5 | 0.170 |
Why?
|
| Nanowires | 1 | 2018 | 6 | 0.160 |
Why?
|
| Receptors, Virus | 2 | 2018 | 74 | 0.160 |
Why?
|
| Silicon | 1 | 2018 | 18 | 0.160 |
Why?
|
| Metabolome | 1 | 2018 | 47 | 0.160 |
Why?
|
| HEK293 Cells | 5 | 2020 | 615 | 0.160 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2010 | 379 | 0.160 |
Why?
|
| Membrane Glycoproteins | 3 | 2018 | 428 | 0.160 |
Why?
|
| Gold | 1 | 2018 | 41 | 0.160 |
Why?
|
| Polymerase Chain Reaction | 3 | 2016 | 927 | 0.160 |
Why?
|
| Organophosphates | 1 | 2017 | 5 | 0.160 |
Why?
|
| Intraepithelial Lymphocytes | 1 | 2017 | 16 | 0.150 |
Why?
|
| Biotin | 1 | 2017 | 44 | 0.150 |
Why?
|
| Molecular Mimicry | 1 | 2017 | 20 | 0.150 |
Why?
|
| Wound Healing | 1 | 2019 | 344 | 0.150 |
Why?
|
| HLA-A Antigens | 4 | 2011 | 44 | 0.150 |
Why?
|
| Dendritic Cells | 3 | 2021 | 425 | 0.150 |
Why?
|
| HLA-B Antigens | 5 | 1997 | 35 | 0.150 |
Why?
|
| DNA Primers | 3 | 2011 | 543 | 0.150 |
Why?
|
| Lipid Bilayers | 1 | 2017 | 134 | 0.150 |
Why?
|
| Tuberculosis Vaccines | 1 | 2016 | 17 | 0.140 |
Why?
|
| rhoB GTP-Binding Protein | 1 | 2016 | 3 | 0.140 |
Why?
|
| Sequence Homology, Amino Acid | 5 | 2014 | 416 | 0.140 |
Why?
|
| Flow Cytometry | 2 | 2016 | 679 | 0.140 |
Why?
|
| Molecular Dynamics Simulation | 2 | 2017 | 245 | 0.140 |
Why?
|
| Sequence Alignment | 3 | 2016 | 351 | 0.140 |
Why?
|
| Jurkat Cells | 2 | 2013 | 77 | 0.140 |
Why?
|
| Viral Proteins | 1 | 2017 | 300 | 0.130 |
Why?
|
| Transduction, Genetic | 1 | 2016 | 153 | 0.130 |
Why?
|
| Amino Acids | 2 | 2014 | 252 | 0.130 |
Why?
|
| Callithrix | 1 | 2015 | 12 | 0.130 |
Why?
|
| Gene Expression | 1 | 2020 | 1284 | 0.130 |
Why?
|
| Cells, Cultured | 6 | 2018 | 2818 | 0.130 |
Why?
|
| Tuberculosis | 1 | 2016 | 110 | 0.130 |
Why?
|
| Mutagenesis | 2 | 2013 | 199 | 0.130 |
Why?
|
| Protein Footprinting | 1 | 2014 | 3 | 0.130 |
Why?
|
| Macaca fascicularis | 1 | 2014 | 108 | 0.130 |
Why?
|
| Signal Transduction | 3 | 2021 | 3241 | 0.120 |
Why?
|
| Melanoma | 1 | 2018 | 459 | 0.120 |
Why?
|
| Transport Vesicles | 1 | 2014 | 8 | 0.120 |
Why?
|
| Glycosylation | 1 | 2014 | 129 | 0.120 |
Why?
|
| Receptors, KIR | 3 | 2010 | 10 | 0.120 |
Why?
|
| Action Potentials | 1 | 2018 | 573 | 0.120 |
Why?
|
| Microbiota | 1 | 2019 | 381 | 0.120 |
Why?
|
| Scattering, Radiation | 1 | 2014 | 114 | 0.120 |
Why?
|
| Dimerization | 2 | 2005 | 143 | 0.120 |
Why?
|
| Tryptophan | 1 | 2014 | 90 | 0.120 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2014 | 213 | 0.120 |
Why?
|
| Fishes | 1 | 2015 | 137 | 0.120 |
Why?
|
| Amino Acid Motifs | 2 | 2012 | 116 | 0.120 |
Why?
|
| Glycolipids | 1 | 2013 | 29 | 0.120 |
Why?
|
| Insecta | 2 | 2021 | 48 | 0.110 |
Why?
|
| Multiprotein Complexes | 1 | 2013 | 95 | 0.110 |
Why?
|
| Protein Folding | 2 | 2013 | 282 | 0.110 |
Why?
|
| HLA-G Antigens | 1 | 2013 | 52 | 0.110 |
Why?
|
| Structural Homology, Protein | 1 | 2012 | 19 | 0.110 |
Why?
|
| Cloning, Molecular | 3 | 2011 | 646 | 0.100 |
Why?
|
| Entropy | 1 | 2012 | 38 | 0.100 |
Why?
|
| Sequence Analysis, DNA | 3 | 2011 | 853 | 0.100 |
Why?
|
| Lysophospholipids | 1 | 2012 | 63 | 0.100 |
Why?
|
| Genes, Overlapping | 1 | 2011 | 4 | 0.100 |
Why?
|
| Autoimmunity | 2 | 2010 | 160 | 0.100 |
Why?
|
| Biological Products | 1 | 2013 | 143 | 0.100 |
Why?
|
| Substrate Specificity | 1 | 2012 | 347 | 0.100 |
Why?
|
| Surface Plasmon Resonance | 2 | 2008 | 46 | 0.100 |
Why?
|
| Haplotypes | 4 | 2002 | 642 | 0.090 |
Why?
|
| Cluster Analysis | 1 | 2011 | 369 | 0.090 |
Why?
|
| Inhibitor of Differentiation Proteins | 1 | 2010 | 11 | 0.090 |
Why?
|
| Membranes | 2 | 2021 | 36 | 0.090 |
Why?
|
| Lysophosphatidylcholines | 1 | 2009 | 18 | 0.090 |
Why?
|
| Hydrogen Bonding | 2 | 2007 | 144 | 0.090 |
Why?
|
| DNA, Complementary | 5 | 2001 | 393 | 0.090 |
Why?
|
| Neurons | 1 | 2018 | 1546 | 0.090 |
Why?
|
| Protein Domains | 2 | 2021 | 128 | 0.090 |
Why?
|
| Gene Expression Regulation | 2 | 2013 | 1920 | 0.080 |
Why?
|
| Molecular Docking Simulation | 2 | 2022 | 46 | 0.080 |
Why?
|
| Circular Dichroism | 1 | 2008 | 117 | 0.080 |
Why?
|
| Neoplasms | 1 | 2023 | 2898 | 0.080 |
Why?
|
| RNA, Small Interfering | 3 | 2016 | 547 | 0.080 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2010 | 206 | 0.080 |
Why?
|
| Mice, Knockout | 3 | 2019 | 1924 | 0.080 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily A | 1 | 2007 | 3 | 0.080 |
Why?
|
| Receptors, NK Cell Lectin-Like | 1 | 2007 | 5 | 0.080 |
Why?
|
| Biological Evolution | 2 | 2017 | 919 | 0.080 |
Why?
|
| Protein Engineering | 3 | 2016 | 140 | 0.080 |
Why?
|
| Mice, Inbred BALB C | 2 | 2020 | 1047 | 0.080 |
Why?
|
| Cell Line, Transformed | 4 | 2001 | 154 | 0.080 |
Why?
|
| Baculoviridae | 1 | 2007 | 34 | 0.080 |
Why?
|
| Disulfides | 1 | 2007 | 64 | 0.070 |
Why?
|
| Lymphoma, T-Cell | 1 | 2007 | 48 | 0.070 |
Why?
|
| Cell Line, Tumor | 2 | 2016 | 2426 | 0.070 |
Why?
|
| Prostatic Neoplasms | 1 | 2017 | 1721 | 0.070 |
Why?
|
| Peptide Fragments | 3 | 2017 | 460 | 0.070 |
Why?
|
| Nuclear Proteins | 1 | 2010 | 696 | 0.070 |
Why?
|
| Pedigree | 3 | 2002 | 966 | 0.070 |
Why?
|
| HeLa Cells | 2 | 2017 | 498 | 0.060 |
Why?
|
| Milk Proteins | 1 | 2023 | 24 | 0.060 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2021 | 425 | 0.060 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2023 | 64 | 0.060 |
Why?
|
| Crystallization | 3 | 2010 | 206 | 0.050 |
Why?
|
| Interferon-gamma | 2 | 2017 | 444 | 0.050 |
Why?
|
| Cebidae | 1 | 2001 | 4 | 0.050 |
Why?
|
| Cercopithecidae | 1 | 2001 | 13 | 0.050 |
Why?
|
| Single Molecule Imaging | 1 | 2021 | 14 | 0.050 |
Why?
|
| Thymocytes | 1 | 2021 | 30 | 0.050 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2001 | 135 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2010 | 2271 | 0.050 |
Why?
|
| Protein Stability | 1 | 2021 | 99 | 0.050 |
Why?
|
| Camelids, New World | 1 | 2020 | 3 | 0.050 |
Why?
|
| Genetic Linkage | 1 | 2002 | 623 | 0.050 |
Why?
|
| Alternative Splicing | 1 | 2001 | 201 | 0.050 |
Why?
|
| RNA, Messenger | 3 | 2001 | 1981 | 0.050 |
Why?
|
| Terminology as Topic | 1 | 2001 | 217 | 0.050 |
Why?
|
| Codon | 1 | 2000 | 124 | 0.050 |
Why?
|
| Interleukin-18 | 1 | 2019 | 26 | 0.050 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2019 | 74 | 0.040 |
Why?
|
| Interleukin-1 | 1 | 2019 | 71 | 0.040 |
Why?
|
| Germ-Free Life | 1 | 2019 | 69 | 0.040 |
Why?
|
| Multigene Family | 1 | 2000 | 202 | 0.040 |
Why?
|
| Interleukin-23 | 1 | 2019 | 54 | 0.040 |
Why?
|
| Oncorhynchus mykiss | 1 | 1998 | 2 | 0.040 |
Why?
|
| Genetic Markers | 1 | 2000 | 476 | 0.040 |
Why?
|
| Fish Proteins | 1 | 1998 | 16 | 0.040 |
Why?
|
| Interleukin-17 | 1 | 2019 | 101 | 0.040 |
Why?
|
| Immune Tolerance | 1 | 2021 | 337 | 0.040 |
Why?
|
| Chemokines | 1 | 1998 | 73 | 0.040 |
Why?
|
| Electrochemical Techniques | 1 | 2018 | 8 | 0.040 |
Why?
|
| Hominidae | 1 | 1999 | 96 | 0.040 |
Why?
|
| Photochemical Processes | 1 | 2018 | 14 | 0.040 |
Why?
|
| Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor | 2 | 2010 | 14 | 0.040 |
Why?
|
| Male | 8 | 2021 | 40965 | 0.040 |
Why?
|
| Ganglia, Spinal | 1 | 2018 | 72 | 0.040 |
Why?
|
| Hepacivirus | 1 | 1999 | 159 | 0.040 |
Why?
|
| Indians, South American | 1 | 1997 | 5 | 0.040 |
Why?
|
| Lepidoptera | 1 | 2017 | 14 | 0.040 |
Why?
|
| Chromosome Mapping | 1 | 2001 | 1074 | 0.040 |
Why?
|
| Lysosomal-Associated Membrane Protein 1 | 1 | 2017 | 5 | 0.040 |
Why?
|
| Epitope Mapping | 1 | 2017 | 16 | 0.040 |
Why?
|
| Leukocyte Immunoglobulin-like Receptor B1 | 1 | 2017 | 2 | 0.040 |
Why?
|
| Spectrophotometry | 1 | 2017 | 106 | 0.040 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2017 | 42 | 0.040 |
Why?
|
| Biotinylation | 1 | 2017 | 41 | 0.040 |
Why?
|
| Serum Albumin, Bovine | 1 | 2017 | 45 | 0.040 |
Why?
|
| K562 Cells | 1 | 2017 | 43 | 0.040 |
Why?
|
| Indians, North American | 1 | 1997 | 48 | 0.040 |
Why?
|
| Primary Cell Culture | 1 | 2017 | 72 | 0.040 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 2017 | 95 | 0.040 |
Why?
|
| X-Ray Diffraction | 1 | 2017 | 124 | 0.040 |
Why?
|
| Lasers | 1 | 2017 | 106 | 0.040 |
Why?
|
| Light | 1 | 2018 | 289 | 0.040 |
Why?
|
| Receptors, Cell Surface | 1 | 2018 | 286 | 0.040 |
Why?
|
| Transcriptome | 1 | 2021 | 580 | 0.040 |
Why?
|
| Hepatitis C | 1 | 1999 | 208 | 0.040 |
Why?
|
| Forkhead Transcription Factors | 1 | 2017 | 166 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2017 | 318 | 0.040 |
Why?
|
| Adenosine Triphosphate | 1 | 2017 | 314 | 0.030 |
Why?
|
| Skin | 1 | 2019 | 554 | 0.030 |
Why?
|
| Models, Genetic | 1 | 2001 | 926 | 0.030 |
Why?
|
| Autoantibodies | 1 | 2017 | 267 | 0.030 |
Why?
|
| HLA-B8 Antigen | 1 | 1995 | 3 | 0.030 |
Why?
|
| DNA | 2 | 1999 | 1294 | 0.030 |
Why?
|
| Bacteria | 1 | 2019 | 447 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 1384 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2016 | 2357 | 0.030 |
Why?
|
| Genetic Loci | 1 | 2016 | 250 | 0.030 |
Why?
|
| Vaccination | 1 | 2016 | 254 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2017 | 712 | 0.030 |
Why?
|
| Receptor-CD3 Complex, Antigen, T-Cell | 1 | 2014 | 4 | 0.030 |
Why?
|
| Neoplastic Stem Cells | 1 | 2016 | 143 | 0.030 |
Why?
|
| Mutation | 2 | 2017 | 3968 | 0.030 |
Why?
|
| Intracellular Space | 1 | 2014 | 38 | 0.030 |
Why?
|
| Actin Cytoskeleton | 1 | 2016 | 192 | 0.030 |
Why?
|
| Macaca mulatta | 1 | 2016 | 459 | 0.030 |
Why?
|
| Diphosphonates | 1 | 2014 | 36 | 0.030 |
Why?
|
| Salmonella typhimurium | 1 | 2013 | 32 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2017 | 683 | 0.030 |
Why?
|
| Amino Acid Substitution | 2 | 2005 | 339 | 0.030 |
Why?
|
| Propionates | 1 | 2013 | 34 | 0.030 |
Why?
|
| Fatty Acid Synthases | 1 | 2013 | 8 | 0.030 |
Why?
|
| Stereoisomerism | 1 | 2013 | 102 | 0.030 |
Why?
|
| Imidazoles | 1 | 2014 | 162 | 0.030 |
Why?
|
| beta 2-Microglobulin | 1 | 2012 | 24 | 0.030 |
Why?
|
| Antibodies, Immobilized | 1 | 2012 | 1 | 0.030 |
Why?
|
| Antibodies, Blocking | 1 | 2012 | 21 | 0.030 |
Why?
|
| Genome, Human | 1 | 1997 | 756 | 0.030 |
Why?
|
| Receptors, KIR2DL4 | 2 | 2002 | 2 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2010 | 559 | 0.030 |
Why?
|
| Apoptosis | 1 | 2018 | 1683 | 0.030 |
Why?
|
| Female | 6 | 2020 | 44532 | 0.030 |
Why?
|
| Rats | 1 | 2018 | 3990 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2017 | 1578 | 0.030 |
Why?
|
| HLA-A2 Antigen | 1 | 2011 | 31 | 0.020 |
Why?
|
| Antigenic Variation | 1 | 2010 | 26 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2017 | 1458 | 0.020 |
Why?
|
| Pongo | 1 | 2010 | 7 | 0.020 |
Why?
|
| Immunologic Factors | 1 | 2012 | 170 | 0.020 |
Why?
|
| Protein Transport | 1 | 2012 | 411 | 0.020 |
Why?
|
| X-Rays | 1 | 2010 | 130 | 0.020 |
Why?
|
| Tumor Necrosis Factor alpha-Induced Protein 3 | 1 | 2010 | 15 | 0.020 |
Why?
|
| Signaling Lymphocytic Activation Molecule Associated Protein | 1 | 2010 | 5 | 0.020 |
Why?
|
| Promyelocytic Leukemia Zinc Finger Protein | 1 | 2010 | 15 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2010 | 134 | 0.020 |
Why?
|
| Multiple Sclerosis | 1 | 2012 | 262 | 0.020 |
Why?
|
| Pregnancy | 1 | 2017 | 2894 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2012 | 371 | 0.020 |
Why?
|
| Phosphorylcholine | 1 | 2009 | 28 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2010 | 268 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2016 | 2232 | 0.020 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2010 | 93 | 0.020 |
Why?
|
| Sphingosine | 1 | 2009 | 71 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2012 | 639 | 0.020 |
Why?
|
| Antigen-Presenting Cells | 1 | 2009 | 139 | 0.020 |
Why?
|
| Models, Biological | 1 | 2016 | 1749 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2010 | 165 | 0.020 |
Why?
|
| Transfection | 1 | 2010 | 896 | 0.020 |
Why?
|
| Histocompatibility Testing | 2 | 1999 | 154 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 879 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2013 | 864 | 0.020 |
Why?
|
| Cytokines | 1 | 2009 | 776 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2010 | 1805 | 0.020 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2005 | 93 | 0.020 |
Why?
|
| Myelin Basic Protein | 1 | 2005 | 49 | 0.020 |
Why?
|
| Peptide Library | 1 | 2005 | 84 | 0.020 |
Why?
|
| Calorimetry | 1 | 2003 | 15 | 0.020 |
Why?
|
| Cytochromes c | 1 | 2003 | 27 | 0.020 |
Why?
|
| Inflammation | 1 | 2009 | 920 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2010 | 1208 | 0.010 |
Why?
|
| Moths | 1 | 2003 | 31 | 0.010 |
Why?
|
| Insect Proteins | 1 | 2003 | 88 | 0.010 |
Why?
|
| Thermodynamics | 1 | 2003 | 309 | 0.010 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily C | 1 | 2002 | 7 | 0.010 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily D | 1 | 2002 | 7 | 0.010 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 2002 | 29 | 0.010 |
Why?
|
| Temperature | 1 | 2003 | 396 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2010 | 1621 | 0.010 |
Why?
|
| Lectins | 1 | 2002 | 84 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2005 | 1540 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2005 | 1991 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2002 | 677 | 0.010 |
Why?
|
| Adult | 1 | 2018 | 25648 | 0.010 |
Why?
|
| Chemokines, CXC | 1 | 1998 | 21 | 0.010 |
Why?
|
| Chemokines, CC | 1 | 1998 | 34 | 0.010 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 1999 | 315 | 0.010 |
Why?
|
| Acute Disease | 1 | 1999 | 826 | 0.010 |
Why?
|
| HLA-B15 Antigen | 1 | 1996 | 3 | 0.010 |
Why?
|
| HLA-A24 Antigen | 1 | 1996 | 20 | 0.010 |
Why?
|
| Thailand | 1 | 1996 | 66 | 0.010 |
Why?
|
| Serology | 1 | 1994 | 3 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 1996 | 439 | 0.010 |
Why?
|
| Liver | 1 | 1999 | 1230 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1995 | 1041 | 0.010 |
Why?
|
| Cysteine | 1 | 1994 | 135 | 0.010 |
Why?
|
| Prospective Studies | 1 | 1999 | 4213 | 0.010 |
Why?
|